Clinical Pain Management


Cancer Pain

The second edition of Cancer Pain delivers broad coverage of the issues that arise in the management of malignancy-related pain, from basic science, through end of life care and associated ethical issues, to therapies, both medical and complementary.

  • Part One reviews basis considerations in cancer pain management, including epidemiology, pharmacology, history-taking and patient evaluation and teamworking.
  • Part Two brings together the drug therapies for cancer pain, their underlying mechanisms of action and potential side-effects.
  • Part Three covers the non-drug therapies, including nerve blocks, stimulation-induced analgesia, radiotherapy, complementary therapies and psychological interventions. The control of symptoms other than pain, so critical to cancer patients, is also considered here.
  • Part Four describes special situations. Cancer pain management in children and older patients, and in the community setting, and pain in the dying patient and the cancer survivor are all covered here.

Edited by

Medical Director and Consultant in Palliative Medicine
St Christopher’s Hospice
London, UK

Michael I Bennett MD FRCP
Professor of Palliative Medicine, International Observatory on End of Life Care
Institute for Health Research
Lancaster University
Lancaster, UK

Chun-Su Yuan MD PhD
Cyrus Tang Professor of Anesthesia and Critical Care
Department of Anesthesia and Critical Care
Pritzker School of Medicine
The University of Chicago
Chicago, IL, USA

Series editor
Christine A Miaskowski RN PhD FAAN
Professor and Associate Dean for Academic Affairs
Department of Physiological Nursing
UCSF School of Nursing
San Francisco, CA, USA

Lead editor
Andrew SC Rice MB BS MD FRCA
Professor of Pain Research, Department of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London; and Honorary Consultant in Pain Medicine, Chelsea and Westminster Hospital Foundation NHS Trust, London, UK